Capricor Therapeutics

1 follower

‌

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.

Industries

Biotechnology

Headquarters

Beverly Hills, United States

Employees

11-50

Links

Org chart

Linda Marbán

Chief Executive Officer

Linda Marbán

Collapse

Aj Bergmann

Chief Financial Officer

Kristi A. H. Elliott

Chief Science Officer

Mark Awadalla

Vice President Clinical Research & Development Operations

Yushi Feng

VP of Regulatory Affairs

Jonathan Tayco

Vice President Of Program Management, Operations And Quality

Joe Z.

Senior IP Counsel

Teams

+24

Research and Development

27 members

Leadership Team

3 members

Finance and Accounting

3 members

Similar companies

Regeneron

91 followers

Natera

13 followers

AbbVie

168 followers

Moderna Therapeutics

104 followers

MilliporeSigma

2 followers

Xencor

1 follower

Anthropic

52 followers

Elanco

20 followers

Fashion Institute of Technology

11 followers

CloudShare

9 followers

Trumid

3 followers

Explore companies